Richard Dean Dr McCormick
Richard Dean Dr McCormick (R-GA) bought $1K-$15K of $ABT (Abbott Laboratories Common Stock (ABT)) on Mar 15, 2023, part of 33 transactions in this filing.
HillSignal flagged 5 timing concerns on this filing — trades that line up closely with related legislative or contract activity.
Companies in this filing · 33
Price Movement Since Trade
How the largest positions have moved from the trade date to the most recent close.
Showing the 6 largest positions. See every transaction in the table below.
Suspicious Timing Detected
5 flagsRichard Dean Dr McCormick bought $1,001 - $15,000 in $AMT on 2023-03-15, 855 days before HR4477 ("PRICE Act") was introduced, which could create new funding for infrastructure improvements.
Richard Dean Dr McCormick bought $1,001 - $15,000 in $ADP on 2023-03-15, 859 days before HR4548 ("Small Nonprofit Retirement Security Act of 2025") was introduced, expanding tax credits for retirement plans.
Richard Dean Dr McCormick bought $1,001 - $15,000 in $COST on 2023-03-15, 867 days before S2512 ("EATS Act of 2025") was introduced, potentially boosting demand for grocery products.
These flags identify timing coincidences between stock trades and legislative activity. They do not imply wrongdoing. Click any bill number or ticker to see the full analysis.
Share This Filing
All Transactions
| Type | Ticker | Asset | Amount | Trade Price | Current | Change | Date |
|---|---|---|---|---|---|---|---|
| BUY | $ABT | Abbott Laboratories Common Stock (ABT) | $1K-$15K | — | $92.48 | — | Mar 15, 2023 |
| BUY | $APD | Air Products and Chemicals, Inc. Common Stock (APD) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | $AMT | American Tower Corporation (AMT) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | $AWK | American Water Works Company, Inc. Common Stock (AWK) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | $ADI | Analog Devices, Inc. - Common Stock (ADI) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | $AAPL | Apple Inc. - Common Stock (AAPL) | $1K-$15K | $152.99 | $273.43 | +78.7% | Mar 15, 2023 |
| BUY | $ADP | Automatic Data Processing, Inc. - Common Stock (ADP) | $1K-$15K | — | $198.53 | — | Mar 15, 2023 |
| BUY | $BARIX | Baron Asset Fund Inst Shs (BARIX)(Mutual Fund) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | $BEXIX | Baron Emerging Markets Fd Inst Shs (BEXIX)(Mutual Fund) | $1K-$15K | — | — | — | Mar 15, 2023 |
| BUY | $BLK | BlackRock, Inc. Common Stock (BLK) | $1K-$15K | — | — | — | Mar 15, 2023 |
Connected Legislative Activity
10 signalsThese bills and contracts share tickers or sectors with this filing's trades.
PrEP and PEP are Prevention Act
The PrEP and PEP are Prevention Act (HR5127) mandates zero-cost coverage of HIV prevention drugs and associated lab monitoring across all US insurance programs. This early-stage bipartisan bill creates direct volume upside for Gilead ($GILD) on branded PrEP, Viatris ($VTRS) on generic PrEP, and Labcorp ($LH) on mandatory diagnostic services. Merck ($MRK) is excluded from the causal chain because its islatravir candidate is not FDA-approved and the bill only covers approved drugs.
Food Date Labeling Act of 2025
The Food Date Labeling Act of 2025 (S.2541) standardizes voluntary date labels but carries no appropriations, is in early-stage committee, and imposes only trivial one-time compliance costs on grocery retailers and food distributors. Near-term market impact is negligible. Real market data shows KR down -6.27% and WMT up +5.1% over 30 days, driven by macro factors entirely unrelated to this procedural bill.
PRICE Act
The PRICE Act (HR4477) is an early-stage authorization bill establishing a grant program for manufactured housing community infrastructure improvements, but it authorizes no direct funding. No publicly-traded REIT is named or directly affected by the bill text. Market impact is negligible now; real analysis requires an appropriations bill.
End the Vaccine Carveout Act
The End the Vaccine Carveout Act (HR 4668) is an early-stage bill with 29 cosponsors that would eliminate the PREP Act liability shield for vaccine manufacturers, exposing $PFE, $MRNA, $GSK, and $JNJ to direct civil lawsuits for vaccine-related injuries. The bill has no near-term passage probability — it was referred to committee in July 2025 with zero further action — but its reintroduction signals continued legislative risk for the vaccine liability framework. Real market data shows all four tickers are down over the trailing 30 days ($PFE -5.09%, $MRNA -7.03%, $GSK -5.16%, $JNJ -5.87%), consistent with broader pharma weakness rather than a discrete bill-event reaction.
MAPWaters Act of 2025
The MAPWaters Act, with a companion bill already signed into law (HR187 → PL 119-62), mandates federal agencies to standardize geospatial waterway data. Trimble ($TRMB) is the primary pure-play beneficiary. The stock is at $66.84, near the bottom of its 52-week range ($62–$87.5), offering a potential entry point if procurement contracts materialize. No funding is authorized directly, so revenue depends on agency procurement budgets.
Price Gouging Prevention Act of 2025
The Price Gouging Prevention Act of 2025 (HR4528) is an early-stage House bill capping corporate margins during 'exceptional market shocks'. Currently referred to committee with zero appropriations, the bill poses a structural long-term regulatory risk to all large-cap companies with pricing flexibility, particularly retailers ($WMT, $AMZN) and integrated energy ($XOM, $CVX). Near-term market impact is low given early legislative stage, but the bill's breadth — covering all goods and services — represents a significant expansion of FTC authority if it advances.
Small Nonprofit Retirement Security Act of 2025
HR4548 opens the tax-exempt small employer market (1.3M 501(c) organizations) to retirement plan subsidies for the first time, creating a new customer acquisition opportunity for payroll and retirement administration providers ADP and PAYX. The bill is in early legislative stages with bipartisan sponsorship.
Blue Shield Privacy Act of 2025
The Blue Shield Privacy Act of 2025 (HR4828) is an early-stage House bill that expands the definition of 'restricted personal information' under federal criminal law to include biometric data, GPS coordinates, license plates, and workplace/school addresses. At referral to the House Judiciary Committee only, with 7 cosponsors and no markup or hearings yet, the bill has no near-term market impact. Real market data show GOOGL at $368.29 (up 6.94% over 7 days, up 28.07% over 30 days), META at $600.42 (down 11.05% over 7 days), AMZN at $258.48 (down 2.09% over 7 days), and MSFT at $400.59 (down 5.66% over 7 days) — these price movements are driven by other factors, not this procedural bill.
EATS Act of 2025
The EATS Act of 2025 remains dormant after introduction 9 months ago, with no committee action or scheduled markups. The bill's near-zero passage probability in a Republican-controlled Senate means zero near-term market impact for grocery retailers like Walmart and Kroger.
Stop Chinese Fentanyl Act of 2025
HR747 (Stop Chinese Fentanyl Act) is an early-stage House bill expanding sanctions definitions for Chinese entities involved in opioid precursors. The bill has been reported by committee but faces a long legislative path. Market data shows chemicals ($DD, $ECL) are near 30-day lows while logistics ($UPS, $FDX, $CHRW) have rallied 12-15% in the last month, indicating no market pricing of this bill's risk. Impact score is low at 2 because the bill authorizes zero funding, remains early-stage, and would affect a narrow subset of US-China chemical trade.
Other Filings by Richard Dean Dr McCormick
Free — no credit card
Get the next McCormick trade the day it's disclosed
HillSignal tracks every Congressional stock filing and federal contract, scores its market impact with AI, and emails you the ones that matter — before they hit the news.
Weekly digest — the congressional activity that actually moved markets that week, in plain English. Free, one email.
Free forever plan · No credit card · Unsubscribe in one click
Want the live terminal too? Create a free account →
Data sourced from the U.S. House of Representatives Office of the Clerk Financial Disclosure system. Stock prices from Financial Modeling Prep. Suspicious timing flags identify coincidences between stock trades and legislative activity and do not imply any wrongdoing or illegal activity. This is not financial advice.